(Q33179207)

23 July 2017

title

Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides (English)

1 reference

23 July 2017

S E Guimond

1

1 reference

23 July 2017

J E Turnbull

series ordinal

2

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

23 July 2017

number of pages

4

1 reference

inferred from page(s)

published in

Current Biology

1 reference

23 July 2017

volume

9

1 reference

23 July 2017

issue

22

1 reference

23 July 2017

page(s)

1343-1346

1 reference

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Heparin structure and interactions with basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Structural basis for FGF receptor dimerization and activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Receptor specificity of the fibroblast growth factor family

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

A strategy for rapid sequencing of heparan sulfate and heparin saccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2800%2980060-3

7 January 2021

10.1016/S0960-9822(00)80060-3

Identifiers

DOI

1 reference

23 July 2017

1 reference